7986 related articles for article (PubMed ID: 10230579)
21. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
[TBL] [Abstract][Full Text] [Related]
22. Psoralens used for cosmetic sun tanning: an unusual cause of extensive burn injury.
Nettelblad H; Vahlqvist C; Krysander L; Sjöberg F
Burns; 1996 Dec; 22(8):633-5. PubMed ID: 8982544
[TBL] [Abstract][Full Text] [Related]
23. The benefits and risks of long-term PUVA photochemotherapy.
Momtaz K; Fitzpatrick TB
Dermatol Clin; 1998 Apr; 16(2):227-34. PubMed ID: 9589196
[TBL] [Abstract][Full Text] [Related]
24. Side-effects of psoralen photochemotherapy (PUVA).
Wolff K
Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
[TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A.
Marx JL; Auerbach R; Possick P; Myrow R; Gladstein AH; Kopf AW
J Am Acad Dermatol; 1983 Dec; 9(6):904-11. PubMed ID: 6643789
[TBL] [Abstract][Full Text] [Related]
26. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
27. Psoralen photochemotherapy.
Gupta AK; Anderson TF
J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):703-34. PubMed ID: 3316316
[TBL] [Abstract][Full Text] [Related]
28. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
[TBL] [Abstract][Full Text] [Related]
29. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
30. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
Bond CA; Grant K; Boh L
Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
[TBL] [Abstract][Full Text] [Related]
31. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
[TBL] [Abstract][Full Text] [Related]
32. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
[TBL] [Abstract][Full Text] [Related]
33. Modifications of PUVA.
Momtaz-T K; Fitzpatrick TB
Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
[TBL] [Abstract][Full Text] [Related]
34. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
[TBL] [Abstract][Full Text] [Related]
35. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
[TBL] [Abstract][Full Text] [Related]
36. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
37. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
Gasparro FP; Liao B; Foley PJ; Wang XM; McNiff JM
Environ Mol Mutagen; 1998; 31(2):105-12. PubMed ID: 9544188
[TBL] [Abstract][Full Text] [Related]
38. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study.
Gahalaut P; Soodan PS; Mishra N; Rastogi MK; Soodan HS; Chauhan S
Photodermatol Photoimmunol Photomed; 2014 Dec; 30(6):294-301. PubMed ID: 24828298
[TBL] [Abstract][Full Text] [Related]
40. Photocarcinogenicity of drugs.
Stern RS
Toxicol Lett; 1998 Dec; 102-103():389-92. PubMed ID: 10022284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
